Graefe-Mody, E U <br/><br/>
Evaluation of the potential for steady-state pharmacokinetic and pharmacodynamic interactions between the DPP-4 inhibitor linagliptin and metformin in healthy subjects.  [electronic resource] 

 -  Current medical research and opinion  Aug 2009 
 - 1963-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1185/03007990903094361  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cross-Over Studies<br/>Dipeptidyl-Peptidase IV Inhibitors--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Linagliptin<br/>Male<br/>Metformin--administration & dosage<br/>Middle Aged<br/>Purines--administration & dosage<br/>Quinazolines--administration & dosage<br/>Young Adult